3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid, Acute
2
Carcinoma, Renal Cell
2
Urinary Bladder Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Pinealoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ovarian Diseases
1
Neuroendocrine Tumors
1
Myeloproliferative Disorders
1
Mammary Neoplasms, Animal
1
Lymphoma
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Kidney Neoplasms
1
Hodgkin Disease
1
Fallopian Tube Neoplasms
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Interventions
fludarabine phosphate
32
Peripheral Blood Stem Cell Transplantation
27
Tacrolimus
26
Cyclophosphamide
26
Whole-Body Irradiation
25
Busulfan
21
Mycophenolic Acid
20
Methotrexate
16
Antilymphocyte Serum
16
Melphalan
12
Cyclosporine
9
Cord Blood Stem Cell Transplantation
8
Filgrastim
7
Etoposide
7
Thiotepa
6
thymoglobulin
5
merphos
5
Sirolimus
5
Rituximab
5
Radiotherapy
5
Methylprednisolone
5
Cytarabine
5
Granulocyte Colony-Stimulating Factor
4
sargramostim
3
fludarabine
3
Flow Cytometry
3
Transplantation
2
Polymerase Chain Reaction
2
Ondansetron
2
Imatinib Mesylate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myeloid, Accelerated Phase
×
entinostat
×
Clear all
No trials found.